Paso Robles wine country has been named Wine Region of the Year by Wine Enthusiast magazine, beating out long-established players.Read More →
Thousand Oaks-based ImmunGene, a cancer treatment firm led by a former Amgen scientist, has raised $9 million from Ally Bridge Group, an investment group with ties to Hong Kong.
ImmunGene’s so-called antibody-cytokine fusion technology could help improve the cancer-cell targeting in therapies. President and CEO Sanjay D. Khare was formerly the scientific director at Amgen, the biotech giant. Prior to the funding, ImmunGene had received several hundred thousand dollars in federal research grants.Read More →
Called MAST, short for Marine Advanced Systems and Technology, the program will create an innovation hub of sorts for companies to test paint, products and devices for their ability to operate in marine environments.Read More →
The 2014 Amgen Tour of California, the largest cycling race in the U.S., will visit four cities in the Tri-Counties in May. The eight-day annual event will roll through Cambria, Pismo Beach and Santa Barbara before concluding at the finish line in Thousand Oaks.Read More →
Santa Barbara County needs to rethink the role of economic development if it is going to retain upper middle class and head of household jobs.
That was the theme of the Oct. 31 annual summit of the Santa Barbara Technology & Industry Association. Held on Halloween day at the Santa Ynez Valley Marriott hotel in Buellton, the event painted a scary economic future for the county.Read More →
Dole Food Co. CEO and Chairman David Murdock has completed a buyout of the company, a deal that takes the Westlake Village-based produce giant private and values it at $1.6 billion.
The merger was approved by shareholders on Oct. 31, the company said. Dole shares will cease trading on the New York Stock Exchange at the close of business on Nov. 1.Read More →